Time to initiation of anti-tuberculosis treatment

被引:68
|
作者
Pirkis, JE
Speed, BR
Yung, AP
Dunt, DR
MacIntyre, CR
机构
[1] FAIRFIELD HOSP,FAIRFIELD,VIC 3078,AUSTRALIA
[2] AUSTRALIAN NATL UNIV,NATL CTR EPIDEMIOL & POPULAT HLTH,CANBERRA,ACT 2601,AUSTRALIA
[3] UNIV WESTERN AUSTRALIA,DEPT PUBL HLTH,NEDLANDS,WA 6009,AUSTRALIA
来源
TUBERCLE AND LUNG DISEASE | 1996年 / 77卷 / 05期
关键词
D O I
10.1016/S0962-8479(96)90111-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To examine delay in initiation of treatment for tuberculosis (TB). Design: Delay in the initiation of treatment for 142 notified TB patients was examined by a retrospective record review. Particular attention was given to the periods between (1) onset of symptoms and initiation of treatment, and (2) determination of sputum positivity and initiation of treatment. An expert panel nominated 30 days and 3 days as 'acceptable' periods for (1) and (2), respectively. Results: Only 31% of patients commenced treatment within 30 days of onset of symptoms. This was so for both sputum smear-positive and negative cases, and was not significantly related to the site of infection, referral source, age, gender or ethnicity of the patient. Of patients with smear-positive pulmonary TB, 86% received treatment within 3 days of this result being demonstrated. Those with a delay of greater than 3 days were all investigated by private doctors through private laboratories. Conclusion: There are appreciable delays in initiation of treatment for TB. Measures to combat these unacceptable delays are discussed.
引用
收藏
页码:401 / 406
页数:6
相关论文
共 50 条
  • [1] Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment
    Roussos, A
    Lagogianni, I
    Gonis, A
    Ilias, I
    Kazi, D
    Patsopoulos, D
    Philippou, N
    RESPIRATORY MEDICINE, 2001, 95 (03) : 187 - 190
  • [2] Anti-tuberculosis treatment and infliximab
    Wallis, RS
    RESPIRATORY MEDICINE, 2005, 99 (12) : 1620 - 1622
  • [3] ANTI-TUBERCULOSIS TREATMENT IN CHILDHOOD
    JOLLY, H
    PRACTITIONER, 1964, 193 (115) : 233 - &
  • [4] Smoking and adherence to anti-tuberculosis treatment
    Underner, M.
    Perriot, J.
    Peiffer, G.
    Meurice, J. -C.
    Dautzenberg, B.
    REVUE DES MALADIES RESPIRATOIRES, 2016, 33 (02) : 128 - 144
  • [5] Plan of Anti-tuberculosis Treatment in Patients with Abdominal Tuberculosis
    Debajyoti Mohanty
    Anindya Halder
    Niraj Srivastava
    Indian Journal of Surgery, 2016, 78 : 166 - 167
  • [6] Plan of Anti-tuberculosis Treatment in Patients with Abdominal Tuberculosis
    Mohanty, Debajyoti
    Halder, Anindya
    Srivastava, Niraj
    INDIAN JOURNAL OF SURGERY, 2016, 78 (02) : 166 - 167
  • [7] Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment
    van Doorn, Cassandra L. R.
    Eckold, Clare
    Ronacher, Katharina
    Ruslami, Rovina
    van Veen, Suzanne
    Lee, Ji-Sook
    Kumar, Vinod
    Kerry-Barnard, Sarah
    Malherbe, Stephanus T.
    Kleynhans, Leanie
    Stanley, Kim
    Hill, Philip C.
    Joosten, Simone A.
    van Crevel, Reinout
    Wijmenga, Cisca
    Critchley, Julia A.
    Walzl, Gerhard
    Alisjahbana, Bachti
    Haks, Marielle C.
    Dockrell, Hazel M.
    Ottenhoff, Tom H. M.
    Vianello, Eleonora
    Cliff, Jacqueline M.
    EBIOMEDICINE, 2022, 82
  • [8] LICHEN DURING ANTI-TUBERCULOSIS TREATMENT WITH ETHAMBUTOL
    GRACIANSKY, PD
    PONS, A
    BULLETIN DE LA SOCIETE FRANCAISE DE DERMATOLOGIE ET DE SYPHILIGRAPHIE, 1975, 82 (03): : 256 - 257
  • [9] THE PATIENT'S PERSPECTIVE OF ANTI-TUBERCULOSIS TREATMENT
    Rang, C. E. J.
    Sahota, N.
    Jayaratnam, A.
    THORAX, 2013, 68 : A87 - A87
  • [10] Chapter 2: Anti-tuberculosis treatment in children
    Maher, Dermot
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2006, 10 (11) : 1205 - 1211